FDA Approves Pfizer Vaccine For Children Ages 5 To 11
On Tuesday, the Food and Drug Administration advisory committee approved the Pfizer vaccine for children ages 5 to 11, a big step forward in getting some 28 million more kids in the U.S. protected against the virus as the delta variant spreads.
However, there’s still one more hurdle before final approval. The federal Food and Drug Administration must now consider formal approval of the shot, and if the agency gives it the green light, an advisory panel with the CDC will then consider it Nov. 2.
Data from the company’s clinical trials found that a low dose of the vaccine – one third of that given to adults and adolescents – was safe and 90% effective.
Dr. Anthony Fauci weighed in on this on Sunday and also said that if approved, the vaccine could be available for the young age group sometime in the first two weeks of November. The Pfizer vaccine is already approved for American adults and adolescents, but it has not yet been fully approved for most school-aged children.
Press Play Below For More:
RELATED: Pfizer Vaccine For Children Ages 5 to 11 Could Be Approved By October